IRIS
LORUSSO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.919
AS - Asia 2.129
EU - Europa 1.885
SA - Sud America 288
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 89
OC - Oceania 6
Totale 7.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.791
IT - Italia 822
SG - Singapore 616
CN - Cina 477
VN - Vietnam 406
BR - Brasile 209
BD - Bangladesh 200
IE - Irlanda 190
SE - Svezia 167
HK - Hong Kong 159
DE - Germania 154
FR - Francia 94
ZA - Sudafrica 75
GB - Regno Unito 72
NL - Olanda 68
AT - Austria 62
IN - India 62
CA - Canada 61
FI - Finlandia 58
RU - Federazione Russa 52
TR - Turchia 32
AR - Argentina 28
JP - Giappone 26
MX - Messico 24
IQ - Iraq 23
PL - Polonia 23
BE - Belgio 21
CZ - Repubblica Ceca 21
PH - Filippine 21
CI - Costa d'Avorio 18
EC - Ecuador 17
KR - Corea 17
UA - Ucraina 17
ES - Italia 16
PK - Pakistan 15
CO - Colombia 10
IR - Iran 10
TH - Thailandia 10
ID - Indonesia 9
LT - Lituania 9
MA - Marocco 8
TN - Tunisia 8
VE - Venezuela 8
CR - Costa Rica 7
SA - Arabia Saudita 7
AU - Australia 6
EG - Egitto 6
GT - Guatemala 6
HN - Honduras 6
JM - Giamaica 6
RO - Romania 6
UY - Uruguay 6
AZ - Azerbaigian 5
GR - Grecia 5
LU - Lussemburgo 5
PY - Paraguay 5
SV - El Salvador 5
UZ - Uzbekistan 5
IL - Israele 4
JO - Giordania 4
BG - Bulgaria 3
GP - Guadalupe 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
RS - Serbia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
EE - Estonia 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
Totale 7.348
Salva come PNG Salva come JPEG
Città #
Ashburn 445
Singapore 369
Dallas 331
San Jose 279
Parma 199
Dublin 190
Santa Clara 167
Chandler 159
Hong Kong 144
Ho Chi Minh City 123
Boardman 107
Council Bluffs 97
Hanoi 89
New York 87
Beijing 81
Munich 77
Bologna 73
Los Angeles 73
Milan 73
Johannesburg 68
Ann Arbor 55
Vienna 54
Shanghai 47
Lauterbourg 44
Buffalo 38
Hefei 35
Dearborn 31
Rome 30
Chicago 26
Helsinki 25
Frankfurt am Main 22
Moscow 22
Nanjing 22
Amsterdam 21
Reggio Emilia 21
Bremen 20
São Paulo 20
Turku 20
Atlanta 19
Brussels 19
Toronto 19
Verona 19
Abidjan 18
Haiphong 18
Montreal 18
Tokyo 18
Modena 17
Brooklyn 16
Izmir 16
London 16
Phoenix 16
Princeton 16
Warsaw 16
Denver 14
Da Nang 13
Baghdad 12
Nanchang 12
Seattle 12
Nuremberg 11
Rio Saliceto 11
Seoul 11
Brescia 10
Columbus 10
Lahore 10
West Jordan 10
Brno 9
Carpi 9
Chongqing 9
Florence 9
North Bergen 9
Olomouc 9
Redondo Beach 9
The Dalles 9
Trento 9
Bari 8
Fremont 8
Guangzhou 8
Hebei 8
Houston 8
Marseille 8
Mumbai 8
Pune 8
Rio de Janeiro 8
Washington 8
Wilmington 8
Charlotte 7
Kyiv 7
Orem 7
Poplar 7
Turin 7
Curitiba 6
Fidenza 6
Guayaquil 6
Jinan 6
Mexico City 6
Stockholm 6
Zhengzhou 6
Baku 5
Belo Horizonte 5
Bengaluru 5
Totale 4.442
Salva come PNG Salva come JPEG
Nome #
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 260
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 244
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 229
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 226
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 221
227P Sexual dimorphism in immune profile of early and advanced NSCLC 214
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 201
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 201
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 201
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 201
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 196
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 189
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 188
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 187
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 178
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 177
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 176
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 176
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 173
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 173
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 172
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 171
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 170
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 169
Isolation and characterization of human lung lymphatic endothelial cells 169
Assessment of Cardiac Patches Suitability for Tissue Engineering 167
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 166
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 165
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 153
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 150
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 145
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 144
5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC 143
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 142
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 142
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling 140
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 140
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 139
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 130
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 121
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 115
Deciphering multifaceted connections between NOTCH1 and SERCA2 proteins in the Darier's disease: a paradigmatic molecular network in the pathogenesis of a Mendelian genodermatosis 72
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 66
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression 48
Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia 39
IDENTIFICATION OF WNK1 AS A DRUGGABLE TARGET IN TAL1-RELATED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA 21
Targeting the pa2g4-npm1 axis triggers nucleolar stress in npm1c aml 17
Specific antitumor activity of the new SERCA inhibitor CAD204520 in lymphoproliferative disorders with NOTCH! PEST domain mutation. 16
Totale 7.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202276 0 0 0 6 1 4 15 7 2 5 4 32
2022/2023767 58 70 40 71 110 72 26 45 214 7 39 15
2023/2024510 24 22 21 26 50 72 83 20 31 48 29 84
2024/20251.247 63 64 92 112 113 82 105 74 116 102 109 215
2025/20263.645 288 227 547 361 385 211 298 160 509 269 231 159
2026/2027748 119 190 176 263 0 0 0 0 0 0 0 0
Totale 7.443